Kwai

Kwai is a standardized dehydrated garlic powder supplement derived from *Allium sativum*, manufactured by Lichtwer Pharma. It is formulated as a non-enteric-coated tablet standardized to contain 1.3% allicin, the primary bioactive component. Kwai exerts its therapeutic effects by inhibiting the cyclooxygenase-mediated thromboxane-synthesis pathway, thereby reducing platelet aggregation. It also inhibits cholesterol biosynthesis and enhances fibrinolysis. The supplement has been investigated for the treatment and prevention of cardiovascular conditions, including hypertension, atherosclerosis, and hypercholesterolemia. Clinical research, including studies at the Medizinische Universität Wien, has evaluated its impact on platelet function and potential interactions with nonsteroidal anti-inflammatory drugs (NSAIDs) like diclofenac.

Brand names

Kwai

Other names

garlic powderAllium sativum